{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:47:36Z","timestamp":1789001256403,"version":"build-2803163510"},"reference-count":180,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.clinre.2013.04.005","type":"journal-article","created":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T10:00:30Z","timestamp":1374228030000},"page":"572-585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis"],"prefix":"10.1016","volume":"37","author":[{"given":"Rodrigo","family":"Liberal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte R.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazaros","family":"Sakkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Bizzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Bogdanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2013.04.005_bib0005","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2013.04.005_bib0010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/gut.2005.075002","article-title":"Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis","volume":"55","author":"Rigamonti","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2013.04.005_bib0015","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2013.04.005_bib0020","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.04.005_bib0025","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1034\/j.1600-0528.2002.017402.x","article-title":"Primary biliary cirrhosis: an orchestrated immune response against epithelial cells","volume":"174","author":"Gershwin","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1016\/j.clinre.2013.04.005_bib0030","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/S0140-6736(10)61965-4","article-title":"Primary biliary cirrhosis","volume":"377","author":"Selmi","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2013.04.005_bib0035","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/gut.15.6.473","article-title":"The epidemiology of primary biliary cirrhosis: a survey of mortality in England and Wales","volume":"15","author":"Hamlyn","year":"1974","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2013.04.005_bib0040","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/hep.1840110317","article-title":"Epidemiology of primary biliary cirrhosis in a defined rural population in the northern part of Sweden","volume":"11","author":"Danielsson","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.04.005_bib0045","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.1840120116","article-title":"The demography of primary biliary cirrhosis in Ontario, Canada","volume":"12","author":"Witt-Sullivan","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.04.005_bib0050","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/gut.36.6.927","article-title":"Low prevalence of primary biliary cirrhosis in Victoria, Australia. Melbourne Liver Group","volume":"36","author":"Watson","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2013.04.005_bib0055","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/hep.510300213","article-title":"Primary biliary cirrhosis once rare, now common in the United Kingdom?","volume":"30","author":"James","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.04.005_bib0060","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/gast.2000.20197","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a US community","volume":"119","author":"Kim","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2013.04.005_bib0065","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1572-0241.2002.06019.x","article-title":"Prevalence of autoimmune liver disease in Alaska Natives","volume":"97","author":"Hurlburt","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0070","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/01.mcg.0000225653.07932.8f","article-title":"Clinical epidemiology of primary biliary cirrhosis: incidence, prevalence, and impact of therapy","volume":"41","author":"Lazaridis","year":"2007","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0075","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00281-009-0164-5","article-title":"Primary biliary cirrhosis","volume":"31","author":"Hohenester","year":"2009","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0080","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/j.gastro.2004.04.064","article-title":"Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations","volume":"127","author":"Sood","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2013.04.005_bib0085","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1080\/00365520701396034","article-title":"Prevalence and incidence of primary biliary cirrhosis are increasing in Finland","volume":"42","author":"Rautiainen","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0090","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.138.10.3525","article-title":"Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis","volume":"138","author":"Gershwin","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0095","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2013.04.005_bib0100","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2002-35704","article-title":"Autoantibodies and autoantigens in autoimmune hepatitis","volume":"22","author":"Strassburg","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clinre.2013.04.005_bib0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-2007-1007185","article-title":"Nuclear envelope protein autoantibodies in primary biliary cirrhosis","volume":"17","author":"Courvalin","year":"1997","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clinre.2013.04.005_bib0110","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1478-3231.2007.01586.x","article-title":"Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis","volume":"27","author":"Rigopoulou","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2013.04.005_bib0115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1568-9972(03)00013-2","article-title":"Antinuclear antibodies specific for primary biliary cirrhosis","volume":"2","author":"Worman","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clinre.2013.04.005_bib0120","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jaut.2010.09.005","article-title":"PBC screen: an IgG\/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis","volume":"35","author":"Liu","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clinre.2013.04.005_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2013.05.002","article-title":"Autoantibodies in primary biliary cirrhosis: Antimitochondrial autoantibodies","author":"Chantran","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0130","doi-asserted-by":"crossref","first-page":"976427","DOI":"10.1155\/2011\/976427","article-title":"Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges","volume":"2011","author":"Rigamonti","year":"2011","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0135","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.cca.2012.03.020","article-title":"Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis","volume":"413","author":"Mytilinaiou","year":"2012","journal-title":"Clin Chim Acta"},{"issue":"4","key":"10.1016\/j.clinre.2013.04.005_bib0140","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.clinre.2012.02.005","article-title":"Autoantibodies in autoimmune hepatitis: antinuclear antibodies (ANA)","volume":"36","author":"Johanet","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0145","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12016-011-8253-3","article-title":"Cutting-edge issues in primary biliary cirrhosis","volume":"42","author":"Folci","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0150","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jaut.2012.05.022","article-title":"The immunopathology of liver granulomas in primary biliary cirrhosis","volume":"39","author":"You","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clinre.2013.04.005_bib0155","first-page":"1615","article-title":"Pathogenesis of primary biliary cirrhosis","volume":"56","author":"Jones","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2013.04.005_bib0160","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.24526","article-title":"Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis","volume":"54","author":"Tsuda","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.04.005_bib0165","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.24355","article-title":"Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis","volume":"54","author":"Rong","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.04.005_bib0170","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaut.2008.05.003","article-title":"CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis","volume":"31","author":"Shimoda","year":"2008","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.clinre.2013.04.005_bib0175","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.clinre.2011.07.013","article-title":"Urinary tract infection as a risk factor for autoimmune liver disease: from bench to bedside","volume":"36","author":"Smyk","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0180","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-2005-916319","article-title":"Genetics and geoepidemiology of primary biliary cirrhosis: following the footprints to disease etiology","volume":"25","author":"Selmi","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clinre.2013.04.005_bib0185","first-page":"189585","article-title":"Primary biliary cirrhosis: family stories","volume":"2011","author":"Smyk","year":"2011","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.clinre.2013.04.005_bib0190","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-4933-8-12","article-title":"Immunopathogenesis of primary biliary cirrhosis: an old wives\u2019 tale","volume":"8","author":"Smyk","year":"2011","journal-title":"Immun Ageing"},{"key":"10.1016\/j.clinre.2013.04.005_bib0195","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12016-008-8087-9","article-title":"Bacteria and primary biliary cirrhosis","volume":"36","author":"Bogdanos","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0200","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.21123","article-title":"Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis","volume":"43","author":"Lan","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.04.005_bib0205","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaut.2008.11.001","article-title":"Hepatic IL-17 responses in human and murine primary biliary cirrhosis","volume":"32","author":"Lan","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clinre.2013.04.005_bib0210","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaut.2010.06.004","article-title":"Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis","volume":"35","author":"Bernuzzi","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clinre.2013.04.005_bib0215","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gut.2003.023937","article-title":"Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort","volume":"53","author":"Prince","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2013.04.005_bib0220","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jhep.2009.11.027","article-title":"Primary biliary cirrhosis: a 2010 update","volume":"52","author":"Poupon","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0225","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/gast.2002.36027","article-title":"Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28years","volume":"123","author":"Prince","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2013.04.005_bib0230","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/gut.2003.025155","article-title":"Fatigue in chronic cholestasis","volume":"53","author":"Milkiewicz","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2013.04.005_bib0235","first-page":"1840","article-title":"The natural history of abdominal pain associated with primary biliary cirrhosis","volume":"89","author":"Laurin","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0905","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","author":"Beuers","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0245","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.04.005_bib0250","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.cgh.2007.07.015","article-title":"Transplantation trends in primary biliary cirrhosis","volume":"5","author":"Lee","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0255","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1111\/j.1572-0241.2007.01235.x","article-title":"Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses","volume":"102","author":"Gong","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0260","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/0002-9343(71)90218-X","article-title":"Primary biliary cirrhosis with scleroderma. Raynaud's phenomenon and telangiectasia. New syndrome","volume":"50","author":"Reynolds","year":"1971","journal-title":"Am J Med"},{"key":"10.1016\/j.clinre.2013.04.005_bib0265","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0016-5085(19)30497-4","article-title":"Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome","volume":"78","author":"Crowe","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2013.04.005_bib0270","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2011.11.005","article-title":"Primary biliary cirrhosis and Sjogren's syndrome: autoimmune epithelitis","volume":"39","author":"Selmi","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clinre.2013.04.005_bib0275","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/ard.46.4.286","article-title":"Prevalence of Sjogren's syndrome in autoimmune diseases","volume":"46","author":"Coll","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinre.2013.04.005_bib0280","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/PL00009532","article-title":"Primary biliary cirrhosis, sicca complex, and dysphagia","volume":"12","author":"Mang","year":"1997","journal-title":"Dysphagia"},{"key":"10.1016\/j.clinre.2013.04.005_bib0285","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/jhep.2001.21165","article-title":"Risk factors for primary biliary cirrhosis in a cohort of patients from the United States","volume":"33","author":"Parikh-Patel","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.04.005_bib0290","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.04.005_bib0295","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/gut.2009.184218","article-title":"Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations","volume":"59","author":"Prince","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2013.04.005_bib0300","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinre.2013.04.005_bib0305","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.autrev.2011.02.005","article-title":"Systemic sclerosis. Introduction","volume":"10","author":"Chighizola","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clinre.2013.04.005_bib0310","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/rheumatology\/keh253","article-title":"Prevalence of systemic sclerosis in a French multi-ethnic county","volume":"43","author":"Le Guern","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clinre.2013.04.005_bib0315","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.semarthrit.2007.05.003","article-title":"Incidence and prevalence of systemic sclerosis: a systematic literature review","volume":"37","author":"Chifflot","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clinre.2013.04.005_bib0320","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","article-title":"Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinre.2013.04.005_bib0325","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11926-003-0045-1","article-title":"Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics, and clinical manifestations","volume":"5","author":"Reveille","year":"2003","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.clinre.2013.04.005_bib0330","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.autrev.2010.09.017","article-title":"Immunogenetics of systemic sclerosis","volume":"10","author":"Dieude","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clinre.2013.04.005_bib0335","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.autrev.2010.09.010","article-title":"Do infections facilitate the emergence of systemic sclerosis?","volume":"10","author":"Grossman","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clinre.2013.04.005_bib0910","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.autrev.2012.05.004","article-title":"Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases","volume":"12","author":"Fenoglio","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clinre.2013.04.005_bib0345","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.autrev.2010.09.014","article-title":"Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality","volume":"10","author":"Nussinovitch","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clinre.2013.04.005_bib0350","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1568-9972(03)00004-1","article-title":"New insights into the pathogenesis of systemic sclerosis","volume":"2","author":"Tamby","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clinre.2013.04.005_bib0355","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.4049\/jimmunol.168.7.3649","article-title":"Oligoclonal T cell expansion in the skin of patients with systemic sclerosis","volume":"168","author":"Sakkas","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0360","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ncprheum0346","article-title":"Mechanisms of disease: the role of immune cells in the pathogenesis of systemic sclerosis","volume":"2","author":"Sakkas","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0365","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1445-5994.1999.tb01586.x","article-title":"Familial risk estimation in systemic sclerosis","volume":"29","author":"Englert","year":"1999","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.clinre.2013.04.005_bib0370","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jaut.2008.05.002","article-title":"Polyautoimmunity and familial autoimmunity in systemic sclerosis","volume":"31","author":"Hudson","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clinre.2013.04.005_bib0375","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.3899\/jrheum.090207","article-title":"Systemic sclerosis: environmental factors","volume":"36","author":"Mora","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0380","first-page":"348","article-title":"Infectious disease as aetiological factor in the pathogenesis of systemic sclerosis","volume":"68","author":"Radic","year":"2010","journal-title":"Neth J Med"},{"key":"10.1016\/j.clinre.2013.04.005_bib0385","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1749-6632.2009.04808.x","article-title":"The role of infections in the immunopathogensis of systemic sclerosis\u00a0\u2013\u00a0evidence from serological studies","volume":"1173","author":"Arnson","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clinre.2013.04.005_bib0390","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1196\/annals.1422.028","article-title":"Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in systemic sclerosis","volume":"1108","author":"Sherer","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clinre.2013.04.005_bib0395","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1365-2133.2010.09633.x","article-title":"Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea","volume":"162","author":"Antiga","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0400","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.clim.2011.01.013","article-title":"Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis","volume":"139","author":"Fenoglio","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0405","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/03009742.2010.528021","article-title":"Altered T-cell and regulatory cell repertoire in patients with diffuse cutaneous systemic sclerosis","volume":"40","author":"Papp","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0410","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0415","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/pgmj.64.748.121","article-title":"The diagnosis and classification of scleroderma (systemic sclerosis)","volume":"64","author":"Barnett","year":"1988","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.clinre.2013.04.005_bib0420","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","article-title":"Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients","volume":"81","author":"Ferri","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clinre.2013.04.005_bib0425","first-page":"104","article-title":"Disease subsets, antinuclear antibody profile, and clinical features in 127\u00a0French and 247\u00a0US adult patients with systemic sclerosis","volume":"34","author":"Meyer","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0430","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00393-008-0291-8","article-title":"[Organ-specific diagnosis in patients with systemic sclerosis: recommendations of the German Network for Systemic Sclerosis (DNSS)]","volume":"67","author":"Hunzelmann","year":"2008","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0435","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/ard.59.5.359","article-title":"Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele","volume":"59","author":"Vlachoyiannopoulos","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinre.2013.04.005_bib0440","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hcm052","article-title":"Scleroderma renal crisis: patient characteristics and long-term outcomes","volume":"100","author":"Penn","year":"2007","journal-title":"QJM"},{"key":"10.1016\/j.clinre.2013.04.005_bib0445","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clinre.2013.04.005_bib0450","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1346-8138.2009.00762.x","article-title":"Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis","volume":"37","author":"Hamaguchi","year":"2010","journal-title":"J Dermatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0455","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.autrev.2012.05.011","article-title":"Autoantibodies in systemic sclerosis","volume":"12","author":"Mehra","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clinre.2013.04.005_bib0460","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/bmj.3.5717.258","article-title":"Scleroderma and primary biliary cirrhosis","volume":"3","author":"Murray-Lyon","year":"1970","journal-title":"Br Med J"},{"key":"10.1016\/j.clinre.2013.04.005_bib0465","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0016-5085(72)80017-9","article-title":"Primary biliary cirrhosis associated with scleroderma","volume":"62","author":"O\u2019Brien","year":"1972","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2013.04.005_bib0470","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJM197309272891306","article-title":"The presentation and diagnosis of 100 patients with primary biliary cirrhosis","volume":"289","author":"Sherlock","year":"1973","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2013.04.005_bib0475","first-page":"281","article-title":"[Primary biliary cirrhosis and scleroderma]","volume":"2","author":"Geffroy","year":"1973","journal-title":"Med Chir Dig"},{"key":"10.1016\/j.clinre.2013.04.005_bib0480","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/ard.37.1.42","article-title":"Rheumatic disorders in primary biliary cirrhosis","volume":"37","author":"Clarke","year":"1978","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinre.2013.04.005_bib0485","first-page":"75","article-title":"Primary biliary cirrhosis and the CREST syndrome: a report of 22 cases","volume":"62","author":"Powell","year":"1987","journal-title":"Q J Med"},{"key":"10.1016\/j.clinre.2013.04.005_bib0490","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1440-1746.1998.tb00758.x","article-title":"Immunological features of patients with primary biliary cirrhosis (PBC) overlapping systemic sclerosis: a comparison with patients with PBC alone","volume":"13","author":"Akimoto","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0495","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1346-8138.1999.tb03503.x","article-title":"Clinical and immunological characterization of patients with systemic sclerosis overlapping primary biliary cirrhosis: a comparison with patients with systemic sclerosis alone","volume":"26","author":"Akimoto","year":"1999","journal-title":"J Dermatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0500","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/ard.60.11.1046","article-title":"Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients","volume":"60","author":"Marasini","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinre.2013.04.005_bib0505","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/qjmed\/hch078","article-title":"Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study","volume":"97","author":"Watt","year":"2004","journal-title":"QJM"},{"key":"10.1016\/j.clinre.2013.04.005_bib0510","first-page":"365","article-title":"Autoimmune associations in primary biliary cirrhosis","volume":"57","author":"Culp","year":"1982","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clinre.2013.04.005_bib0515","first-page":"129","article-title":"Primary biliary cirrhosis and rheumatic diseases: a clinical, immunological and immunogenetical study","volume":"4","author":"Modena","year":"1986","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0520","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/ard.2002.001826","article-title":"Hepatic manifestations of autoimmune rheumatic diseases","volume":"63","author":"Abraham","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinre.2013.04.005_bib0525","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jhep.2010.02.019","article-title":"Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis","volume":"53","author":"Corpechot","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0530","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02232678","article-title":"Chronic disease of the liver associated with systemic scleroderma","volume":"9","author":"Bartholomew","year":"1964","journal-title":"Am J Dig Dis"},{"key":"10.1016\/j.clinre.2013.04.005_bib0535","first-page":"68","article-title":"Precipitating autoantibodies to mitochondrial proteins in progressive systemic sclerosis","volume":"58","author":"Gupta","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0540","first-page":"1075","article-title":"Reactivity of anti-mitochondrial antibodies in primary biliary cirrhosis and systemic sclerosis","volume":"91","author":"Chou","year":"1992","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.clinre.2013.04.005_bib0545","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1002\/art.24958","article-title":"Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1\/Th2 cytokines","volume":"60","author":"Gourh","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinre.2013.04.005_bib0550","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archderm.1961.01580150005001","article-title":"Systemic scleroderma. A clinical study of 727 cases","volume":"84","author":"Tuffanelli","year":"1961","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0555","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0002-9343(69)90044-8","article-title":"Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls","volume":"46","author":"D\u2019Angelo","year":"1969","journal-title":"Am J Med"},{"key":"10.1016\/j.clinre.2013.04.005_bib0560","first-page":"85","article-title":"[Primary biliary cirrhosis and scleroderma: long-term benign course of a complex autoimmune disease]","volume":"15","author":"Pollak","year":"1985","journal-title":"Leber Magen Darm"},{"key":"10.1016\/j.clinre.2013.04.005_bib0565","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s00063-002-1123-2","article-title":"[Reynolds syndrome\u00a0\u2013\u00a0a rare combination of 2 autoimmune diseases]","volume":"97","author":"Stadie","year":"2002","journal-title":"Med Klin (Munich)"},{"key":"10.1016\/j.clinre.2013.04.005_bib0570","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0016-5085(85)90325-7","article-title":"Asymptomatic primary biliary cirrhosis. A progress report on long-term follow-up and natural history","volume":"89","author":"Beswick","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2013.04.005_bib0575","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/BOR.0b013e3283367c17","article-title":"The genetics of scleroderma (systemic sclerosis)","volume":"22","author":"Agarwal","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0580","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/ng.627","article-title":"Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis","volume":"42","author":"Liu","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.clinre.2013.04.005_bib0585","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1002\/art.22196","article-title":"Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis","volume":"54","author":"Gourh","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinre.2013.04.005_bib0590","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaut.2009.08.014","article-title":"Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations","volume":"34","author":"Gourh","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clinre.2013.04.005_bib0595","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/gut.50.6.743","article-title":"Primary biliary cirrhosis: seeking the silent partner of autoimmunity","volume":"50","author":"Sutton","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2013.04.005_bib0600","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11926-004-0061-9","article-title":"Antibodies in scleroderma: direct pathogenicity and phenotypic associations","volume":"6","author":"Chung","year":"2004","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.clinre.2013.04.005_bib0605","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.dld.2009.05.005","article-title":"Primary biliary cirrhosis-specific autoantibodies in patients with systemic sclerosis","volume":"41","author":"Mytilinaiou","year":"2009","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinre.2013.04.005_bib0610","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/hep.1840060609","article-title":"Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis?","volume":"6","author":"Mitchison","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.04.005_bib0615","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00262092","article-title":"Anticentromere antibody\u00a0\u2013\u00a0clinical associations. A study of 44 patients","volume":"14","author":"Caramaschi","year":"1995","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.clinre.2013.04.005_bib0620","doi-asserted-by":"crossref","first-page":"8654","DOI":"10.1073\/pnas.85.22.8654","article-title":"Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis","volume":"85","author":"Fussey","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinre.2013.04.005_bib0625","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/hep.1840100402","article-title":"Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis","volume":"10","author":"Mutimer","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.04.005_bib0630","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1073\/pnas.90.6.2527","article-title":"Combinatorial autoantibodies to dihydrolipoamide acetyltransferase, the major autoantigen of primary biliary cirrhosis","volume":"90","author":"Cha","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinre.2013.04.005_bib0635","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1089-3261(03)00104-1","article-title":"Antimitochondrial and other autoantibodies","volume":"7","author":"Bogdanos","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clinre.2013.04.005_bib0640","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.21583","article-title":"A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis","volume":"45","author":"Oertelt","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.04.005_bib0645","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1073\/pnas.84.14.4979","article-title":"Analysis of anticentromere autoantibodies using cloned autoantigen CENP-B","volume":"84","author":"Earnshaw","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinre.2013.04.005_bib0650","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.autrev.2010.09.025","article-title":"Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F","volume":"10","author":"Fritzler","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clinre.2013.04.005_bib0655","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0190-9622(85)80038-4","article-title":"Evaluation of methods for detection of anticentromere antibodies and other antinuclear antibodies","volume":"12","author":"Beutner","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0660","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/art.1780301214","article-title":"Detection of anticentromere antibodies using cloned autoantigen CENP-B","volume":"30","author":"Rothfield","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinre.2013.04.005_bib0665","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/1529-0131(199904)42:3<455::AID-ANR10>3.0.CO;2-3","article-title":"A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity","volume":"42","author":"Tan","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinre.2013.04.005_bib0670","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1073\/pnas.77.3.1627","article-title":"Autoantibody to centromere (kinetochore) in scleroderma sera","volume":"77","author":"Moroi","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinre.2013.04.005_bib0675","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/art.1780230602","article-title":"Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome","volume":"23","author":"Tan","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinre.2013.04.005_bib0680","first-page":"1488","article-title":"Clinical and serological heterogeneity in patients with anticentromere antibodies","volume":"32","author":"Miyawaki","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0685","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinre.2013.04.005_bib0690","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/art.11113","article-title":"Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies","volume":"49","author":"Reveille","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinre.2013.04.005_bib0695","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1053\/sarh.2001.20268","article-title":"Systemic sclerosis in 3\u00a0US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants","volume":"30","author":"Reveille","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clinre.2013.04.005_bib0700","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/art.20065","article-title":"The TNF-863A allele strongly associates with anticentromere antibody positivity in scleroderma","volume":"50","author":"Sato","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinre.2013.04.005_bib0705","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/ard.47.8.634","article-title":"Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six-year follow-up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting","volume":"47","author":"Kallenberg","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinre.2013.04.005_bib0710","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/art.10760","article-title":"A comparison between anti-Th\/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement","volume":"48","author":"Mitri","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinre.2013.04.005_bib0715","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/art.1780370111","article-title":"Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis","volume":"37","author":"Kuwana","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinre.2013.04.005_bib0720","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2133.2007.08392.x","article-title":"The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis","volume":"158","author":"Hamaguchi","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0725","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/rheumatology\/keg170","article-title":"The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis","volume":"42","author":"Hesselstrand","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clinre.2013.04.005_bib0730","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/archderm.1979.04010080014013","article-title":"Cancer and scleroderma","volume":"115","author":"Duncan","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0735","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/art.1780281204","article-title":"Cancer and systemic sclerosis. An epidemiologic study","volume":"28","author":"Roumm","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinre.2013.04.005_bib0740","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/1097-0142(19950901)76:5<910::AID-CNCR2820760528>3.0.CO;2-T","article-title":"Incidence of cancer among patients with systemic sclerosis","volume":"76","author":"Rosenthal","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.clinre.2013.04.005_bib0745","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s100670050029","article-title":"Anticentromere antibody as a risk factor for cancer in patients with systemic sclerosis","volume":"19","author":"Higuchi","year":"2000","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0750","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000314634","article-title":"Malignancies in autoimmune rheumatic diseases\u00a0\u2013\u00a0a mini-review","volume":"57","author":"Szekanecz","year":"2011","journal-title":"Gerontology"},{"key":"10.1016\/j.clinre.2013.04.005_bib0755","first-page":"1994","article-title":"Autoantibodies in patients with systemic sclerosis and cancer: a case-control study","volume":"30","author":"Derk","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0760","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00005792-200203000-00005","article-title":"Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival","volume":"81","author":"Scussel-Lonzetti","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clinre.2013.04.005_bib0765","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0889-857X(21)00738-9","article-title":"Autoantibodies in scleroderma","volume":"18","author":"Rothfield","year":"1992","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clinre.2013.04.005_bib0770","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.cca.2011.08.024","article-title":"Anti-CENPI autoantibodies in scleroderma patients with features of autoimmune liver diseases","volume":"412","author":"Hamdouch","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clinre.2013.04.005_bib0775","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.2169\/internalmedicine.31.1348","article-title":"Anti-centromere antibody and CREST syndrome in patients with primary biliary cirrhosis","volume":"31","author":"Shoji","year":"1992","journal-title":"Intern Med"},{"key":"10.1016\/j.clinre.2013.04.005_bib0780","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0025-6196(12)62059-X","article-title":"The anticentromere antibody: disease specificity and clinical significance","volume":"59","author":"Powell","year":"1984","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clinre.2013.04.005_bib0785","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/ard.41.6.612","article-title":"Anticentromere antibody in primary biliary cirrhosis","volume":"41","author":"Bernstein","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinre.2013.04.005_bib0790","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3109\/00365529108998588","article-title":"High prevalence of autoimmune liver disease in patients with multiple nuclear dot, anti-centromere, and mitotic spindle antibodies","volume":"26","author":"Hansen","year":"1991","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0795","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2230.1994.tb01199.x","article-title":"Anticentromere antibodies (ACA): clinical distribution and disease specificity","volume":"19","author":"Chan","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0800","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/jaut.1994.1030","article-title":"The association of primary biliary cirrhosis and systemic sclerosis is not accounted for by cross reactivity between mitochondrial and centromere antigens","volume":"7","author":"Whyte","year":"1994","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clinre.2013.04.005_bib0805","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.3899\/jrheum.090340","article-title":"Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients","volume":"36","author":"Assassi","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0810","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","article-title":"Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group","volume":"70","author":"Avouac","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinre.2013.04.005_bib0815","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1191\/096120301682430212","article-title":"Morphologic capillary changes and manifestations of connective tissue diseases in patients with primary biliary cirrhosis","volume":"10","author":"Fonollosa","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.clinre.2013.04.005_bib0820","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2249.1990.tb03325.x","article-title":"Autoantibodies to mitochondrial and centromere antigens in primary biliary cirrhosis and systemic sclerosis","volume":"81","author":"McHugh","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0825","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/art.1780260714","article-title":"Anticentromere antibodies in primary biliary cirrhosis","volume":"26","author":"Makinen","year":"1983","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinre.2013.04.005_bib0830","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2036.2007.03433.x","article-title":"Antibodies to SS-A\/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis","volume":"26","author":"Granito","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2013.04.005_bib0835","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2009.08.009","article-title":"A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis","volume":"34","author":"Agmon-Levin","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clinre.2013.04.005_bib0840","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/jaut.1994.1008","article-title":"Eukaryotic expression of recombinant human centromere autoantigen and its use in a novel ELISA for diagnosis of CREST syndrome","volume":"7","author":"Stahnke","year":"1994","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clinre.2013.04.005_bib0845","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/rheumatology\/34.5.407","article-title":"Frequency of autoantibodies to a major epitope on the carboxyl terminal fragment of CENP-B in patients with autoimmune disease","volume":"34","author":"Whyte","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0850","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s10620-008-0359-y","article-title":"Clinical characteristics of patients with hepatitis C virus-related chronic liver disease seropositive for anticentromere antibody","volume":"54","author":"Himoto","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinre.2013.04.005_bib0855","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0016-5085(94)90078-7","article-title":"Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis","volume":"107","author":"Czaja","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2013.04.005_bib0860","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1023\/A:1018880429469","article-title":"Antibodies to Ro\/La, Cenp-B, and snRNPs antigens in autoimmune hepatitis of North America versus Asia: patterns of immunofluorescence, ELISA reactivities, and HLA association","volume":"43","author":"Parveen","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinre.2013.04.005_bib0865","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1440-1746.1995.tb01597.x","article-title":"High prevalence of antibodies to recombinant CENP-B in primary biliary cirrhosis: nuclear immunofluorescence patterns and ELISA reactivities","volume":"10","author":"Parveen","year":"1995","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0870","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S1542-3565(04)00465-3","article-title":"Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure?","volume":"2","author":"Yang","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0875","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10238-008-0150-6","article-title":"The value of antinuclear antibodies in primary biliary cirrhosis","volume":"8","author":"Gao","year":"2008","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.clinre.2013.04.005_bib0880","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2169\/internalmedicine.50.4462","article-title":"Risk factors and prediction of long-term outcome in primary biliary cirrhosis","volume":"50","author":"Ishibashi","year":"2011","journal-title":"Intern Med"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.clinre.2013.04.005_bib0885","first-page":"S412","article-title":"Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosis","volume":"37","author":"Nakamura","year":"2007","journal-title":"Hepatol Res"},{"key":"10.1016\/j.clinre.2013.04.005_bib0890","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1872-034X.2010.00631.x","article-title":"Analysis of HLA-DRB1 polymorphisms in Japanese patients with primary biliary cirrhosis (PBC): the HLA-DRB1polymorphism determines the relative risk of antinuclear antibodies for disease progression in PBC","volume":"40","author":"Nakamura","year":"2010","journal-title":"Hepatol Res"},{"key":"10.1016\/j.clinre.2013.04.005_bib0895","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00535-011-0417-7","article-title":"Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients","volume":"46","author":"Aiba","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.clinre.2013.04.005_bib0900","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1007\/s10620-010-1268-4","article-title":"Autoantibodies as prognostic markers in autoimmune liver disease","volume":"55","author":"Czaja","year":"2010","journal-title":"Dig Dis Sci"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740113000922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740113000922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:18:18Z","timestamp":1761895098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740113000922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":180,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S2210740113000922"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2013.04.005","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2013.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}